Wendy Galpern is a Neurology physician affiliated with Johnson & Johnson. OpenAlex indexes 74 publications with 4,661 citations (h-index 31).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Phase 1 Studies of the Anti-Tau Monoclonal Antibody JNJ-63733657 in Healthy Participants and Participants with Alzheimer's Disease
The Journal of Prevention of Alzheimer s Disease
2024 - Discovery and Functional Characterization of hPT3, a Humanized Anti-Phospho Tau Selective Monoclonal Antibody
Journal of Alzheimer s Disease
2020 - Development and Validation of a High Sensitivity Assay for Measuring p217 + tau in Cerebrospinal Fluid
Journal of Alzheimer s Disease
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Balaji Laxmanan, MD
Johnson & Johnson
Marvin Sperling, MD
Johnson & Johnson
Wayne Drevets, MD
Johnson & Johnson
Hanneke Schuitemaker
Johnson & Johnson
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”